Influenza
Conditions
Keywords
influenza, vaccine, public health, preventable disease, vaccine history, point-of-care
Brief summary
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.
Detailed description
This is a multi-site, observational study investigating the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. Data will be collected in the bi-directional IIS. Aggregate de-identified data will be reported to the researchers at the midpoint and conclusion of the study. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.
Interventions
Administration, number and types, of vaccine(s) by a pharmacist
Identification of unmet vaccination needs and having those needs met
Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs
Sponsors
Study design
Eligibility
Inclusion criteria
* Individuals eligible to be enrolled in the study include any person at least 18 years of age receiving an influenza vaccination from a participating pharmacy site.
Exclusion criteria
* n/a
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and types of vaccines administered | Change from baseline rates at 6 months |
| Number of unmet vaccination needs identified and met | through study completion, an average of 6 months |
| Number of times the pharmacist reviewed the vaccination forecast and educated the patient on his/her vaccine needs | through study completion, an average of 6 months |
Countries
United States